| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.300 | Therapeutic | disease | CTD_human | E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. | 19839049 | 2010 | ||||
|
0.300 | Therapeutic | disease | CTD_human | Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma. | 17520682 | 2007 | ||||
|
0.300 | Therapeutic | disease | CTD_human | MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro. | 24014025 | 2013 | ||||
|
0.300 | Biomarker | disease | CTD_human | Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma. | 17520682 | 2007 | ||||
|
0.300 | Biomarker | disease | CTD_human | MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro. | 24014025 | 2013 | ||||
|
0.300 | Therapeutic | disease | CTD_human | 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. | 23921149 | 2013 | ||||
|
0.300 | Biomarker | disease | CTD_human | 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. | 23921149 | 2013 | ||||
|
0.300 | Biomarker | disease | CTD_human | E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. | 19839049 | 2010 |